Investor List:

Top Diagnostics Seed Investors in Washington, D.C. (6)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Diagnostics investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of George C. Petrocheilos, Managing Partner at Catalio Capital
George C. Petrocheilos
Catalio Capital·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Baltimore (MD), Investors in Athens (Greece), Investors in New York (NY)
Investors in Drug Delivery (Seed), Investors in Diagnostics (Seed), Investors in Drug Delivery (Seed), Investors in Cybersecurity (Seed), Investors in Diagnostics (Seed), Investors in Medical Devices (Seed), Investors in Drug Delivery (Seed), Investors in Robotics (Seed), Investors in BioTech (Seed), Investors in Cybersecurity (Seed), Investors in Diagnostics (Seed), Investors in Medical Devices (Seed), Investors in Robotics (Seed), Investors in BioTech (Seed), Investors in Medical Devices (Seed), Investors in Cybersecurity (Seed), Investors in Robotics (Seed), Investors in BioTech (Seed), Investors in Diagnostics (Series A), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series A), Investors in Cybersecurity (Series A), Investors in Drug Delivery (Series A), Investors in Medical Devices (Series A), Investors in Diagnostics (Series A), Investors in Robotics (Series A), Investors in BioTech (Series A), Investors in Medical Devices (Series A), Investors in Diagnostics (Series A), Investors in Cybersecurity (Series A), Investors in Robotics (Series A), Investors in BioTech (Series A), Investors in Medical Devices (Series A), Investors in Cybersecurity (Series A), Investors in Robotics (Series A), Investors in BioTech (Series A), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series B), Investors in Cybersecurity (Series B), Investors in Diagnostics (Series B), Investors in Robotics (Series B), Investors in Diagnostics (Series B), Investors in Medical Devices (Series B), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Diagnostics (Series B), Investors in Cybersecurity (Series B), Investors in Robotics (Series B), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Robotics (Series B), Investors in Cybersecurity (Series B), Investors in BioTech (Series B), Investors in Washington, D.C. (Other Lists), Investors in New York City (Other Lists)
Photo of Elias Zerhouni, Venture Partner at Catalio Capital
Elias Zerhouni
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Baltimore (MD)
Photo of Bert Vogelstein, Venture Partner at Catalio Capital
Bert Vogelstein
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Cambridge (MA), Investors in Boston (MA), Investors in Baltimore (MD)
Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in BioTech (Seed), Investors in Diagnostics (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in BioTech (Series A), Investors in Diagnostics (Series A), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Washington, D.C. (Other Lists), Investors in Boston / New England (Other Lists)
Photo of Alison   (Ali) Perez, Investor at Lockheed Martin Ventures
Alison (Ali) Perez
Sweet spot: $2.5M
Range: $500K - $5.0M
Investors in Washington (DC)
Investors in Diagnostics (Seed), Investors in Data Services (Seed), Investors in IoT (Seed), Investors in AI (Seed), Investors in Digital Health (Seed), Investors in Health IT (Seed), Investors in Diagnostics (Seed), Investors in Data Services (Seed), Investors in IoT (Seed), Investors in Digital Health (Seed), Investors in Health IT (Seed), Investors in AI (Seed), Investors in Diagnostics (Series A), Investors in IoT (Series A), Investors in Data Services (Series A), Investors in AI (Series A), Investors in Digital Health (Series A), Investors in Health IT (Series A), Investors in Diagnostics (Series A), Investors in Data Services (Series A), Investors in IoT (Series A), Investors in Digital Health (Series A), Investors in AI (Series A), Investors in Health IT (Series A), Investors in IoT (Series B), Investors in Diagnostics (Series B), Investors in Data Services (Series B), Investors in AI (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Diagnostics (Series B), Investors in IoT (Series B), Investors in Data Services (Series B), Investors in AI (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Washington, D.C. (Other Lists)
Photo of Andrew Lee, Senior Associate at Northpond Ventures
Andrew Lee
Northpond Ventures·Senior Associate
Sweet spot: $10
Range: $1 - $40
Investors in Washington (D.C.), Investors in San Francisco (CA)
Investors in Chemicals (Seed), Investors in Drug Delivery (Seed), Investors in Diagnostics (Seed), Investors in Drug Delivery (Seed), Investors in Chemicals (Seed), Investors in AgTech (Seed), Investors in Drug Delivery (Seed), Investors in Pharmaceuticals (Seed), Investors in Diagnostics (Seed), Investors in Chemicals (Seed), Investors in BioTech (Seed), Investors in AgTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Diagnostics (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in AgTech (Seed), Investors in BioTech (Seed), Investors in Chemicals (Series A), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series A), Investors in Diagnostics (Series A), Investors in Chemicals (Series A), Investors in AgTech (Series A), Investors in Drug Delivery (Series A), Investors in Pharmaceuticals (Series A), Investors in Diagnostics (Series A), Investors in Chemicals (Series A), Investors in BioTech (Series A), Investors in AgTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Diagnostics (Series A), Investors in BioTech (Series A), Investors in AgTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Chemicals (Series B), Investors in Drug Delivery (Series B), Investors in Chemicals (Series B), Investors in Drug Delivery (Series B), Investors in AgTech (Series B), Investors in Diagnostics (Series B), Investors in Pharmaceuticals (Series B), Investors in Drug Delivery (Series B), Investors in BioTech (Series B), Investors in Chemicals (Series B), Investors in Diagnostics (Series B), Investors in AgTech (Series B), Investors in Pharmaceuticals (Series B), Investors in Diagnostics (Series B), Investors in BioTech (Series B), Investors in AgTech (Series B), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series B), Investors in Washington, D.C. (Other Lists), Investors in Diverse Investors (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Nathan Livingston, Analyst at Catalio Capital
Nathan Livingston
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Baltimore (MD)
Get new data & insights delivered to your inbox
Firms investing in this space